Psoriasis: Adalimumab Biosimilars Comparable With Originator ...Middle East

Biosimilars show comparable safety with Humira among new users with psoriasis in a multinational cohort study, but discontinuations were higher among those who switched from Humira to a biosimilar. Medscape Medical News

Hence then, the article about psoriasis adalimumab biosimilars comparable with originator was published today ( Thursday 28/11/2024 - 10:00 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Psoriasis: Adalimumab Biosimilars Comparable With Originator )

Also on site :

• UK to list 65-year-olds as reservists amid Russia threat claims – Telegraph
• AI boom fuels fears of an industry bubble (VIDEO)
• Amazon Has 'Super Warm' and ‘Soft' Mini Sheepskin Boots on Sale for $50, and They're 'Worth Every Penny'